Learn more about Semaglutide at Madison Medispa, or schedule your free semaglutide consultation today!
A new study suggests that GLP-1 receptor agonists do not affect muscle mass any more than weight loss caused by caloric restriction, and this appears to be true for strength as well [1]
This review bridges the gap between the fundamental molecular machinery of ferroptosis and its burgeoning relevance to clinical cardiology
In markets like Germany, France, and the Nordics, where both obesity and proactive health trends are high, there is strong potential for targeted NPD and retailer-led innovation. Nestls Vital Pursuit, a portion-controlled, nutrient-filled frozen food line spanning pizzas and sandwich melts to wholegrain bowls, launched in 2024 to support GLP-1 users in the United States
Your physician will design a protocol tailored to your response and long-term goals